Diabetes and Impaired Fracture Healing: A Narrative Review of Recent Literature

Overview

Journal Curr Osteoporos Rep

Publisher Current Science

Specialties Endocrinology
Orthopedics

Date 2022 Aug 12

PMID 35960475

Authors

Mina Tanios

Bradley Brickman

Emily Cage

Kassem Abbas

Cody Smith

Marina Atallah

Sudipta Baroi

Beata Lecka-Czernik

Affiliations

Soon will be listed here.

Abstract

Purpose Of The Review: Diabetes mellitus is a chronic metabolic disorder commonly encountered in orthopedic patients. Both type 1 and type 2 diabetes mellitus increase fracture risk and impair fracture healing. This review examines complex etiology of impaired fracture healing in diabetes.

Recent Findings: Recent findings point to several mechanisms leading to orthopedic complications in diabetes. Hyperglycemia and chronic inflammation lead to increased formation of advanced glycation end products and generation of reactive oxygen species, which in turn contribute to the disruption in osteoblast and osteoclast balance leading to decreased bone formation and heightening the risk of nonunion or delayed union as well as impaired fracture healing. The mechanisms attributing to this imbalance is secondary to an increase in pro-inflammatory mediators leading to premature resorption of callus cartilage and impaired bone formation due to compromised osteoblast differentiation and their apoptosis. Other mechanisms include disruption in the bone's microenvironment supporting different stages of healing process including hematoma and callus formation, and their resolution during bone remodeling phase. Complications of diabetes including peripheral neuropathy and peripheral vascular disease also contribute to the impairment of fracture healing. Certain diabetic drugs may have adverse effects on fracture healing. The pathophysiology of impaired fracture healing in diabetic patients is complex. This review provides an update of the most recent findings on how key mediators of bone healing are affected in diabetes.

Citing Articles

The effects of gabapentin and pregabalin on fracture healing: A histological, radiological, and biomechanical analysis.

Acan A, Aydin M, Bulmus O, Ozcan E, Karakilic A, Turan G Jt Dis Relat Surg. 2024; 36(1):200-209.

PMID: 39719918 PMC: 11734844. DOI: 10.52312/jdrs.2025.2042.

Oblique Lumbar Interbody Fusion Combined With Anterolateral Fixation and Cement Augmentation for the Treatment of Degenerative Lumbar Diseases in the Elderly Population: A Retrospective Study.

Han W, He L, Wang F, Zhao X, Jin C Orthop Surg. 2024; 17(2):446-459.

PMID: 39627870 PMC: 11787981. DOI: 10.1111/os.14315.

Meta-analysis of proteomics data from osteoblasts, bone, and blood: Insights into druggable targets, active factors, and potential biomarkers for bone biomaterial design.

Schmidt J, Adamowicz K, Arend L, Lehmann J, List M, Poh P J Tissue Eng. 2024; 15:20417314241295332.

PMID: 39620099 PMC: 11605762. DOI: 10.1177/20417314241295332.

Higher charlson comorbidity index score correlates with higher rate of pseudoarthrosis following short-segment lumbar fusion surgery.

Eksi M, Tanriverdi N, Topaloglu F, Duymaz U, Yesilyurt S, Kuru Bektasoglu P Eur Spine J. 2024; 34(1):215-224.

PMID: 39604552 DOI: 10.1007/s00586-024-08571-5.

Nanocarrier-Assisted Delivery of Berberine Promotes Diabetic Alveolar Bone Regeneration by Scavenging ROS and Improving Mitochondrial Dysfunction.

Ming Y, He X, Zhao Z, Meng X, Zhu Y, Tan H Int J Nanomedicine. 2024; 19:10263-10282.

PMID: 39399826 PMC: 11471107. DOI: 10.2147/IJN.S475320.

References

Wukich D . Diabetes and its negative impact on outcomes in orthopaedic surgery. World J Orthop. 2015; 6(3):331-9. PMC: 4390895. DOI: 10.5312/wjo.v6.i3.331. View

Jiao H, Xiao E, Graves D . Diabetes and Its Effect on Bone and Fracture Healing. Curr Osteoporos Rep. 2015; 13(5):327-35. PMC: 4692363. DOI: 10.1007/s11914-015-0286-8. View

Zura R, Xiong Z, Einhorn T, Watson J, Ostrum R, Prayson M . Epidemiology of Fracture Nonunion in 18 Human Bones. JAMA Surg. 2016; 151(11):e162775. DOI: 10.1001/jamasurg.2016.2775. View

Lecka-Czernik B . Diabetes, bone and glucose-lowering agents: basic biology. Diabetologia. 2017; 60(7):1163-1169. PMC: 5487688. DOI: 10.1007/s00125-017-4269-4. View

Schwartz A . Diabetes, bone and glucose-lowering agents: clinical outcomes. Diabetologia. 2017; 60(7):1170-1179. DOI: 10.1007/s00125-017-4283-6. View

Laurent M, Cook M, Gielen E, Ward K, Antonio L, Adams J . Lower bone turnover and relative bone deficits in men with metabolic syndrome: a matter of insulin sensitivity? The European Male Ageing Study. Osteoporos Int. 2016; 27(11):3227-3237. DOI: 10.1007/s00198-016-3656-x. View

Hygum K, Starup-Linde J, Harslof T, Vestergaard P, Langdahl B . MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol. 2017; 176(3):R137-R157. DOI: 10.1530/EJE-16-0652. View

Dhaliwal R, Ewing S, Vashishth D, Semba R, Schwartz A . Greater Carboxy-Methyl-Lysine Is Associated With Increased Fracture Risk in Type 2 Diabetes. J Bone Miner Res. 2021; 37(2):265-272. PMC: 8828668. DOI: 10.1002/jbmr.4466. View

Claes L, Recknagel S, Ignatius A . Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012; 8(3):133-43. DOI: 10.1038/nrrheum.2012.1. View

10.

Lafage-Proust M, Roche B, Langer M, Cleret D, Vanden Bossche A, Olivier T . Assessment of bone vascularization and its role in bone remodeling. Bonekey Rep. 2015; 4:662. PMC: 4389660. DOI: 10.1038/bonekey.2015.29. View

11.

Bragdon B, Bahney C . Origin of Reparative Stem Cells in Fracture Healing. Curr Osteoporos Rep. 2018; 16(4):490-503. PMC: 6041151. DOI: 10.1007/s11914-018-0458-4. View

12.

Doherty L, Wan M, Kalajzic I, Sanjay A . Diabetes impairs periosteal progenitor regenerative potential. Bone. 2020; 143:115764. PMC: 7770068. DOI: 10.1016/j.bone.2020.115764. View

13.

Zhang E, Miramini S, Patel M, Richardson M, Ebeling P, Zhang L . Role of TNF-α in early-stage fracture healing under normal and diabetic conditions. Comput Methods Programs Biomed. 2021; 213:106536. DOI: 10.1016/j.cmpb.2021.106536. View

14.

Marin C, Luyten F, Van der Schueren B, Kerckhofs G, Vandamme K . The Impact of Type 2 Diabetes on Bone Fracture Healing. Front Endocrinol (Lausanne). 2018; 9:6. PMC: 5787540. DOI: 10.3389/fendo.2018.00006. View

15.

Alharbi M, Zhang C, Lu C, Milovanova T, Yi L, Ryu J . FOXO1 Deletion Reverses the Effect of Diabetic-Induced Impaired Fracture Healing. Diabetes. 2018; 67(12):2682-2694. PMC: 6245226. DOI: 10.2337/db18-0340. View

16.

Sundararaghavan V, Mazur M, Evans B, Liu J, Ebraheim N . Diabetes and bone health: latest evidence and clinical implications. Ther Adv Musculoskelet Dis. 2017; 9(3):67-74. PMC: 5349336. DOI: 10.1177/1759720X16687480. View

17.

Ko K, Syverson A, Kralik R, Choi J, DerGarabedian B, Chen C . Diabetes-Induced NF-κB Dysregulation in Skeletal Stem Cells Prevents Resolution of Inflammation. Diabetes. 2019; 68(11):2095-2106. PMC: 6804629. DOI: 10.2337/db19-0496. View

18.

Kalyanaraman H, Schwaerzer G, Ramdani G, Castillo F, Scott B, Dillmann W . Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes. Diabetes. 2018; 67(4):607-623. PMC: 5860855. DOI: 10.2337/db17-0965. View

19.

Jiang H, Wang Y, Meng J, Chen S, Wang J, Qiu Y . Effects of Transplanting Bone Marrow Stromal Cells Transfected with CXCL13 on Fracture Healing of Diabetic Rats. Cell Physiol Biochem. 2018; 49(1):123-133. DOI: 10.1159/000492848. View

20.

Hoff P, Gaber T, Strehl C, Schmidt-Bleek K, Lang A, Huscher D . Immunological characterization of the early human fracture hematoma. Immunol Res. 2016; 64(5-6):1195-1206. DOI: 10.1007/s12026-016-8868-9. View